Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksander Lenert

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Current Allergy and Asthma Reports|November 17, 2011
Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunityDamir Matesic, Aleksander Lenert, Petar Lenert
Biomedicines|September 27, 2025
Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS)Lindsay Moy, Aleksander Lenert, Petar Lenert
Patient Education and Counseling|June 14, 2021
A patient-centered gout information value chain: a scoping reviewMaranda J Russell, Sujin Kim, Aleksander Lenert
Drug Design, Development and Therapy|March 24, 2017
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to dateAleksander Lenert, Timothy B Niewold, Petar Lenert
The American Journal of Case Reports|September 28, 2025
Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder CancerIbiyemi Oke, Aleksander Lenert, Brian L Swick, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 7, 2020
Accuracy of US Administrative Claims Codes for the Diagnosis of Autoinflammatory SyndromesAleksander Lenert, Maranda J Russell, Suzanne Segerstrom, et al.
Rheumatology (Oxford, England)|May 7, 2020
Comment on: Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database: replyAleksander Lenert, GYeon Oh, Michael J Ombrello, et al.
Rheumatology (Oxford, England)|January 23, 2020
Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims databaseAleksander Lenert, GYeon Oh, Michael J Ombrello, et al.
Journal of Inflammation Research|February 25, 2022
The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current PerspectivesErin Sternhagen, Brittany Bettendorf, Aleksander Lenert, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 17, 2025
Accuracy and Performance Characteristics of Administrative Codes for the Diagnosis of Autoinflammatory Syndromes: A Discovery and Validation StudySaeyun Lee, Sujin Kim, Suzanne Segerstrom, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Current Allergy and Asthma Reports|November 17, 2011
Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunityDamir Matesic, Aleksander Lenert, Petar Lenert
Biomedicines|September 27, 2025
Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS)Lindsay Moy, Aleksander Lenert, Petar Lenert
Patient Education and Counseling|June 14, 2021
A patient-centered gout information value chain: a scoping reviewMaranda J Russell, Sujin Kim, Aleksander Lenert
Drug Design, Development and Therapy|March 24, 2017
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to dateAleksander Lenert, Timothy B Niewold, Petar Lenert
The American Journal of Case Reports|September 28, 2025
Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder CancerIbiyemi Oke, Aleksander Lenert, Brian L Swick, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 7, 2020
Accuracy of US Administrative Claims Codes for the Diagnosis of Autoinflammatory SyndromesAleksander Lenert, Maranda J Russell, Suzanne Segerstrom, et al.
Rheumatology (Oxford, England)|May 7, 2020
Comment on: Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database: replyAleksander Lenert, GYeon Oh, Michael J Ombrello, et al.
Rheumatology (Oxford, England)|January 23, 2020
Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims databaseAleksander Lenert, GYeon Oh, Michael J Ombrello, et al.
Journal of Inflammation Research|February 25, 2022
The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current PerspectivesErin Sternhagen, Brittany Bettendorf, Aleksander Lenert, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 17, 2025
Accuracy and Performance Characteristics of Administrative Codes for the Diagnosis of Autoinflammatory Syndromes: A Discovery and Validation StudySaeyun Lee, Sujin Kim, Suzanne Segerstrom, et al.
Pageof 4